title: Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter.
abstract: Galactosialidosis (GS) is a human neurodegenerative disease caused by a deficiency of lysosomal protective protein/cathepsin A (PPCA). The GS mouse model resembles the severe human condition, resulting in nephropathy, ataxia, and premature death. To rescue the disease phenotype, GS mice were transplanted with bone marrow from transgenic mice overexpressing human PPCA specifically in monocytes/macrophages under the control of the colony stimulating factor-1 receptor promoter. Transgenic macrophages infiltrated and resided in all organs and expressed PPCA at high levels. Correction occurred in hematopoietic tissues and nonhematopoietic organs, including the central nervous system. PPCA-expressing perivascular and leptomeningeal macrophages were detected throughout the brain of recipient mice, although some neuronal cells, such as Purkinje cells, continued to show storage and died. GS mice crossed into the transgenic background reflected the outcome of bone marrow-transplanted mice, but the course of neuronal degeneration was delayed in this model. These studies present definite evidence that macrophages alone can provide a source of corrective enzyme for visceral organs and may be beneficial for neuronal correction if expression levels are sufficient.
authors.affiliation: Department of Genetics, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.
authors.forename: C N
authors.initials: CN
authors.lastname: Hahn
authors.forename: M
authors.initials: M
authors.lastname: del Pilar Martin
authors.forename: X Y
authors.initials: XY
authors.lastname: Zhou
authors.forename: L W
authors.initials: LW
authors.lastname: Mann
authors.forename: A
authors.initials: A
authors.lastname: d'Azzo
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002268:Carboxypeptidases / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics*; D043402:Cathepsin A; D064987:Cell- and Tissue-Based Therapy; D015316:Genetic Therapy; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000235:genetics / Q000628:therapy*; D008264:Macrophages / Q000502:physiology / Q000637:transplantation*; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic / Q000235:genetics; D016186:Receptor, Macrophage Colony-Stimulating Factor / Q000235:genetics
chemical_list: D016186:Receptor, Macrophage Colony-Stimulating Factor; D002268:Carboxypeptidases; C468629:CTSA protein, human; D043402:Cathepsin A